| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |